GSO IEC TR 63183:2022
Gulf Standard
Current Edition
·
Approved on
12 May 2022
·
Guidance on error and warning messages for software used in radiotherapy
GSO IEC TR 63183:2022 Files
No files are available for this standard right now!
GSO IEC TR 63183:2022 Scope
IEC TR 63183:2019 provides guidance on the usage and form of error or warning messages written for software used in RADIOTHERAPY. It does not replace any requirements existing in the safety standards but is meant to be used as a supplement to existing standards on usability by providing specific examples in the field of RADIOTHERAPY.
The two main goals of this document are
1) to present in a concise manner the best practices and design guidelines for good message dialogs, and
2) to illustrate these design guidelines with specific examples from the field of radiation oncology.
This document is intended to be read by the following MANUFACTURERS’ employees and representatives:
– engineering department members including: software engineers, RISK managers, quality assurance engineers, technical writers, etc.;
– usability and human factors engineers;
– marketing representatives (product marketing, product managers, business analysts).
Throughout this document, unless specifically called out, these guidelines apply to all categories of messages summarily called error or warning messages (e.g. critical error, warning, system status, informational, routine interlock messages).
The two main goals of this document are
1) to present in a concise manner the best practices and design guidelines for good message dialogs, and
2) to illustrate these design guidelines with specific examples from the field of radiation oncology.
This document is intended to be read by the following MANUFACTURERS’ employees and representatives:
– engineering department members including: software engineers, RISK managers, quality assurance engineers, technical writers, etc.;
– usability and human factors engineers;
– marketing representatives (product marketing, product managers, business analysts).
Throughout this document, unless specifically called out, these guidelines apply to all categories of messages summarily called error or warning messages (e.g. critical error, warning, system status, informational, routine interlock messages).
Best Sellers From Health Sector
GSO 2017:2023
Gulf Standard
Personal Care and Baby Wet Wipes
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
GSO 2241:2023
Gulf Standard
Cosmetic Products - Body Cleaners
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
GSO 2063:2023
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
GSO 2302:2022
Gulf Standard
Cosmetic Products – Face Masks
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
Recently Published from Health Sector
GSO ISO 17069:2024
ISO 17069:2020
Gulf Standard
Accessible design — Consideration and assistive products for accessible meeting
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
![ISO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_iso_sml.png)
GSO ISO 11608-6:2024
ISO 11608-6:2022
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 6: On-body delivery systems
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
![ISO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_iso_sml.png)
GSO ISO 16256:2024
ISO 16256:2021
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
![ISO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_iso_sml.png)
GSO ISO 14708-3:2024
ISO 14708-3:2017
Gulf Standard
Implants for surgery — Active implantable medical devices — Part 3: Implantable neurostimulators
![GSO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_gso_sml.png)
![ISO Standard](https://static.gso.org.sa/gso-uicore/assets/images/logo_iso_sml.png)